Around 27 molecules that can activate a specialized protein called PPAR-delta have been found out by a group of researchers. This protein can fight against obesity, fatty liver, diabetic nephropathy and also heals wounds.
News of these findings was published today in Scientific Reports, a Nature journal, and was made possible thanks to a new, award-winning algorithm that Goldblum's team developed. This algorithm sifted through a database of 1.56 million molecules and picked out 27 with a strong therapeutic potential, as determined by biologists at the Novartis Genomic (GNF) Institute in San Diego.
Fatty Liver Disease: A Growing Health Problem in India
Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and is a rapidly growing health problem in India.
Advertisement
‘Around 21 out of 27 molecules being discovered have the potential to be used as medications, especially for fatty liver disease, which has no treatment until now.’
Tweet it Now
To date, these new molecules are undergoing pharmaceutical evaluations to treat two main health conditions. The first is Fatty Liver Disease, also known as NASH (Non-Alcoholic SteatoHeptatis). This disease currently has no cure and is a leading cause of liver cancer in the Western world. The second is obesity. PPAR-delta activation has the potential to increase physical endurance and trim waistlines by getting muscle cells to burn more fat. Future evaluations will hopefully include testing treatments for improved wound healing, and to prevent kidney toxicity in diabetics.
Professor Goldblum is cautiously optimistic about these findings. "With such a large group of highly active molecules, there is a high probability to find treatments for several common diseases. However, we should wait till all the experiments are done before we get our hopes up too high," he shared.
![Fibroscan for Fatty Liver Cirrhosis and Fibrosis]( "Fibroscan for Fatty Liver Cirrhosis and Fibrosis")
Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to estimate the degree of fatty infiltration in the liver.
To date, there is much pharmaceutical interest in Goldblum's new molecules. Integra Holdings, Hebrew University's biotech company, determined that 21 of the 27 have the potential to reach pharmaceutical success, especially as a possible cure for Fatty Liver disease. Additionally, Israel's Heller Institute of Medical Research is currently testing PPAR-delta's physical endurance properties on mice. Goldblum predicts that in a few years we will hopefully be seeing several of these molecules in the pipeline for clinical studies on humans.
Source: Eurekalert
Fibroscan for Fatty Liver Cirrhosis and Fibrosis
Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to estimate the degree of fatty infiltration in the liver.
Advertisement
To date, there is much pharmaceutical interest in Goldblum's new molecules. Integra Holdings, Hebrew University's biotech company, determined that 21 of the 27 have the potential to reach pharmaceutical success, especially as a possible cure for Fatty Liver disease. Additionally, Israel's Heller Institute of Medical Research is currently testing PPAR-delta's physical endurance properties on mice. Goldblum predicts that in a few years we will hopefully be seeing several of these molecules in the pipeline for clinical studies on humans.
Source: Eurekalert
Alcoholic Liver Disease
Encyclopedia section of medindia gives general information about Alcoholic Liver Disease.
Advertisement
 Liver CirrhosisLiver cirrhosis is a chronic liver disease that arises due to alcoholism, hepatitis, or other conditions. Liver failure patients are treated with transplantation. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
A latest research suggests that the quality of a person's post-work recovery in the evening can impact their mood when they resume work the next day.
Researchers are working on new strategies and solutions for sleep apnea to ward off a range of health risks including cognitive decline.
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.